Fig. 1 · Structure

Documents & Downloads

NVP-BVU972

Cat. No. A11150 CAS 1185763-69-2

C-Met inhibitor

NVP-BVU972 is a selective MET inhibitor.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Met 14 nM

NVP-BVU972 Research Summary

This section summarizes 1 in vitro study of NVP-BVU972 from 1 published reference. In vitro models include HeLa cells infected with VSV-GFP.

NVP-BVU972 In Vitro Studies

In HeLa cells infected with VSV-GFP, the tested compounds at 10 μM significantly reduced viral replication compared with DMSO as a control. The readout was GFP fluorescence images. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Reduced Viral Replication in Infected HeLa Cells

Cell-based study · HeLa cells infected with VSV-GFP [1]

In HeLa cells infected with VSV-GFP, the tested compounds at 10 μM significantly reduced viral replication compared with DMSO as a control. The readout was GFP fluorescence images.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
GFP fluorescence imagesReported result 10 μM: all three compounds significantly reduced viral replication[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 μM
Vehicle
DMSO
Co-treatment
Other interventions in this design: VSV-GFP MOI = 0.1. Compound effect isolated by the comparison: DMSO as a control.
Reported limits
Not stated in the sentences used: route, schedule.
Methods and source locations

Compound reported in the paper: NVP-BVU972

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Experimental validation of DeepAVC predictions identifies MNS as a potent broad-spectrum antiviral compound (S244, S254); Methods > Cell culture and viral infection (S397)

GFP fluorescence images: GFP fluorescence images; comparator: DMSO as a control — Results > Experimental validation of DeepAVC predictions identifies MNS as a potent broad-spectrum antiviral compound (S244, S254)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1185763-69-2
Applications C-Met inhibitor
Formula C20H16N6
Molecular Weight 340.4
SMILES
CN1C=C(C=N1)C2=NN3C(=NC=C3CC4=CC5=C(C=C4)N=CC=C5)C=C2

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 67 mg/mL (196.83 mM)
Water Insoluble
Ethanol 67 mg/mL

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

NVP-BVU972 Research References

  1. [1] Kang B, Zhao Y, Chen X, et al. Bridging antiviral drug discovery with a large language model-powered framework. Commun Biol (2026). PMID: 42156934 DOI: 10.1038/s42003-026-10291-z Source material

Added to your cart

View Cart Checkout
Loading...